Benzinga's Top Upgrades

Analysts at Wells Fargo upgraded
Enzymotec LtdENZY
from Market Perform to Outperform. Enzymotec shares closed at $8.90 yesterday. Baird upgraded
AramarkARMK
to Outperform. The target price for Aramark has been raised from $36 to $37. Aramark shares closed at $31.59 yesterday. JP Morgan upgraded
Spectra Energy Partners, LPSEP
from Neutral to Overweight. The target price for Spectra Energy Partners has been raised from $55 to $61. Spectra Energy Partners shares closed at $51.15 yesterday. Analysts at Stifel Nicolaus upgraded
Microsoft CorporationMSFT
from Hold to Buy. Microsoft shares closed at $46.74 yesterday. Brean Capital upgraded
EZchip Semiconductor LtdEZCH
from Hold to Buy. EZChip Semiconductor shares closed at $18.81 yesterday. BMO Capital upgraded
Merck & Co., Inc. MRK
from Market Perform to Outperform. The target price for Merck has been raised from $65 to $70. Merck shares closed at $58.27 yesterday. Analysts at Goldman Sachs upgraded
Green Plains IncGPRE
from Neutral to Buy. The target price for Green Plains has been raised from $29 to $30. Green Plains shares closed at $21.85 yesterday. Analysts at Morgan Stanley upgraded
Lincoln National CorporationLNC
from Equal-weight to Overweight. Lincoln National shares closed at $55.03 yesterday. Analysts at Barclays upgraded
Legg Mason IncLM
from Equal-weight to Overweight. The target price for Legg Mason has been raised from $55 to $57. Legg Mason shares closed at $48.31 yesterday. Desjardins upgraded
CAE, Inc. (USA) CAE
from Hold to Buy. CAE shares closed at $11.38 yesterday.

Posted In: Asset Management & Custody BanksFinancialsLife & Health Insurancetop upgradesUpgradesAnalyst Ratings